New hope for accurate prognosis of prostate and blood cancers using 3D telomeric imaging and Lamin A/C

Genetic mutations are known to be a factor in the development of cancer.

Professor Sabine Mai of the University of Manitoba, Canada, has been examining the links between genomic instability and cancer using 3D imaging of the genome. She has also collaborated on cutting-edge research, utilising a potential biomarker called Lamin A/C for determining the aggressiveness of Hodgkin’s lymphoma and the severity of Multiple Myeloma. This research is a first step toward circumventing […]

Read More…

X-ray histotomography: Characterising every cell of a whole organism

Histology is a powerful technique to study thin slices of tissue samples.

Histology is a powerful technique used to distinguish normal and abnormal cells and tissue. In practice, only a small sampling of thin, 2-dimensional slices is readily available for diagnosis. In contrast, micro-CT allows full-volume, 3-dimensional (3D) imaging of biological samples. By optimising micro-CT, a multidisciplinary team led by Dr Keith Cheng from Pennsylvania State University created X-ray histotomography, a technique […]

Read More…

New 3D technology to help in the battle against brain tumours

Dr. Darin T. Okuda Research Outreach

Dr. Darin T. Okuda is a clinician-scientist and professor of Neurology and Neurotherapeutics at the University of Texas Southwestern Medical Center in Dallas. Dr. Okuda strives to transform healthcare by developing new diagnostic tools that challenge current clinical practices. His research group recently designed a novel method to visualise brain tumours in three-dimension (3D). This latest research aims to revolutionise […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION